Search results
Results from the WOW.Com Content Network
The FASEB Journal is a peer-reviewed scientific journal related to experimental biology. The journal was established in 1987 and has been published since 2020 [1] by Wiley on behalf of the Federation of American Societies for Experimental Biology. It is published monthly and contains special collections throughout the year.
The Federation of American Societies for Experimental Biology (FASEB), based in Rockville, Maryland, is a non-profit organization of scientific societies in the United States. With a focus on the biological and biomedical sciences, the federation represents scientists in such fields as anatomy , physiology , immunology , biochemistry ...
From 1975 to 2001, [15] Weissmann was the founding editor of the journal, Inflammation; from 1979 to 1984, he edited MD Magazine, and from 2006 to 2016 he served as editor-in-chief of The FASEB Journal. At the time of his death, he was the book review editor of that journal.
Starting in 2012 these publications are only offered online. The society copublishes a wholly open access journal with the British Pharmacological Society and Wiley entitled Pharmacology Research & Perspectives. ASPET also publishes a quarterly newsletter, The Pharmacologist, and, from 2001 to 2011, Molecular Interventions magazine.
She is the founder of the Boston Angiogenesis Meeting, which started its annual meetings in 1998. She is the Editor-in-Chief of the journal Microvascular Research, [6] and has been an associate editor of The American Journal of Pathology. She has also been on the editorial board of FASEB Journal. [7]
This category is for academic and scientific journals published by learned and professional societies. Journals that are published by a separate publisher (whether a commercial publishing company or a university press) on behalf of a society should be categorized under that publisher (see Category:Academic journals by publisher); these journals may also be included in Category:Academic ...
PDE4A inhibition is a target of a number of drugs including: [8] [9] [10] rolipram (antidepressant and antiinflammatory) and cilomilast (antiinflammatory) – inhibits PDE4A isoforms 1, 2, 6, and 7
He has served on the Annual Review of Nutrition's editorial committee and continues to serve on the FASEB Journal editorial board. Zeisel is a member of the World Cancer Research Fund's Expert Panel on “Food, Nutrition and the Prevention of Cancer: A Global Perspective.”